|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Dermatitis | |||||
| Healthy | |||||
| Neoplasm | |||||
| Urticaria | |||||
| Vesiculobullous Skin Disease | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Neoplasms | |||||
| Skin Diseases | |||||
| Skin Diseases, Vesiculobullous | |||||
| 3 | More general conditions related to this trial | ||||
| Hypersensitivity | |||||
| Hypersensitivity, Immediate | |||||
| Immune System Diseases | |||||
| Skin Diseases, Vascular | |||||
| 4 | Sponsors listed in this trial | ||||
| National Cancer Institute (NCI) | |||||